Generations

Annual Report 2022

Innovation drives us at Boehringer Ingelheim as we strive to positively impact lives of humans and animals with our innovative solutions. In 2022 we were able to help more people than ever before.

The excitement about our growing pipeline and the success of our current portfolio, for patients and animals alike, makes us confident about the future, and we are energized to continue to transform lives for generations and reach even more people who will benefit from our products.

Hubertus von Baumbach, Chairman of the Board of Managing Directors

Nina Schmid
Nina Schmid

Ingelheim, Germany

“I go to work for my future self to preserve the environment as we know it now.”

Nina Schmid,Trainee Corp. EHS&S
Ding Cheng
Ding Cheng

Shanghai, China

“I’m always curious about how we can transfer our academic research into the real world and make an impact to our patients.”

Ding Cheng,Data Scientist BIX

Watch
Video

Bok Oh
Bok Oh

Ridgefield, USA

“Not too many people can wake up knowing that they are actually a part of something that’s live changing.”

Bok Oh,Oncology Sales Consultant

Watch
Video

Dr. Joanne Maki
Dr. Joanne Maki

Athens, USA

“I know we are making a difference. We are saving lives. How can you not be passionate about that.”

Dr. Joanne Maki,Senior Veterinarian, Public Health
Missy Pappion
Missy Pappion

Duluth, USA

“We’re making it better for people generations after me.”

Missy Pappion,Senior Art Director, Digital Marketing Pet Vet

Watch
Video

Dr. Trent Bliss
Dr. Trent Bliss

Duluth, USA

“My passion is people. I’m reaching more people, I’m helping more people, I’m transforming how people practice.”

Dr. Trent Bliss,Prof. Services Veterinarian
Fangya Qiang
Fangya Qiang

Shanghai, China

“There are so many opportunities around the globe. That allows me not only to grow as a person, but also to contribute to society and the business.”

Fangya Qiang,Head EHS&S
Dr. Marzieh Funk
Dr. Marzieh Funk

Biberach, Germany

“I go to work to find new treatments for patients with mental health disorders.”

Dr. Marzieh Funk,Principal Scientist
Generations

A global team with a common purpose

Two very different Boehringer Ingelheim employees share, how they are very similar in terms of the values they appreciate.

Read More
Generations

What’s your “why”?

Boehringer Ingelheim asked its employees: What does our purpose mean to you personally, what’s your “why”? Here is what some of them answered.

Read More
Milestones

2022
in focus

An overview of dates that were important for Boehringer Ingelheim last year.

Read More
Human Pharma

Combating a “threat to global health security”

AMR poses a serious threat to global health. Boehringer Ingelheim strives to bring about a decisive shift in the battle against resistant bacteria.

Read More
Human Pharma

Research-led results for interconnected complex diseases

Cardio, renal and metabolic diseases can have complex interdependencies. Some of them can be treated with the same medicine.

Read More
Human Pharma

The Unwearable Collection™: A fashion line no one would dare choose

A four-piece collection from Dutch fashion designer Bart Hess visualizes the painful experience of people living with generalized pustular psoriasis (GPP).

Read More
Human Pharma

The benefits of shared research in human and animal health

There is a close connection between humans and animals when it comes to their health and wellbeing. An interview with Clive Wood and Eric Haaksma.

Read More
Animal Health

The benefits of shared research in human and animal health

There is a close connection between humans and animals when it comes to their health and wellbeing. An interview with Clive Wood and Eric Haaksma.

Read More
Animal Health

Ensuring a better life for our longer-lived pets

Boehringer Ingelheim supports people in caring for their aging pets’ health with a broad portfolio of medicines and forward-looking research.

Read More
Research

The unfolding story of molecular biology

The research activities at the Institute of Molecular Pathology in Vienna hold the promise of developing medical breakthroughs in the future.

Read More
Digitalization

Innovation: From people to data to patients

How Boehringer Ingelheim uses computer-aided biology to create new opportunities throughout their entire organization.

Read More
Digitalization

More data for more users means more value

Boehringer Ingelheim is establishing a data ecosystem called “dataland” to help all its employees take decisions based on data.

Read More
Digitalization

Helping bridge China’s gap
in stroke care

The Chinese healthcare system is facing the huge challenge to offer rehabilitation of stroke patients. A digital option is intended to help close the treatment gap.

Read More
Human Resources

A personal tale of a people-first approach

Continuously and jointly, the employees at Boehringer Ingelheim shape a work environment that lets every one of them thrive.

Read More
Sustainability

As trained talk therapists, Zimbabwean grandmothers are saving lives

Psychiatrist Dr. Dixon Chibanda launched the “Friendship Bench” project which trains grandmothers to become lay therapists.

Read More
Sustainability

A commitment to sustainability, supported by three pillars

More Health, More Potential, More Green – these are the pillars of Boehringer Ingelheim’s sustainability strategy. And it’s been bringing the desired results.

Read More
Humanitarian aid

“We don’t want to live in fear anymore”

The war in Ukraine continues to cause suffering and hardship. The Polish and the German Red Cross are making every effort to help.

Read More

Key figures

EUR 5.0billion expenditure in Research and
Development
Human PharmaEUR 18.5billion
equivalent to20.9%of total net sales
Animal HealthEUR 4.6billion
Biopharmaceutical
Contract Manufacturing
EUR 1.0billion

Letters

Christian Boehringer

The Shareholders’ Perspective

Read More
Managing Directors

The Board of Managing Directors

Read More